Product Information
QULIPTA 10 MG TABLET is a brand product labeled by AbbVie Inc., priced at $38.3609 per EA under NDC 00074709530. Its NADAC has been published 219 times since Apr 20, 2022.
Strength
10 mg/1
Manufacturer
AbbVie Inc.NDC
00074709530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA215206On Market Since
9/30/2021
Pharmacological Classes
Price Statistics
The NADAC for QULIPTA 10 MG TABLET has been published 219 times since Apr 20, 2022, and over the history we have for it it has risen 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.3609 per EA |
|---|---|
| All-time high | $38.4108 (Jun 10, 2026) |
| All-time low | $31.8211 (Apr 20, 2022) |
| 52-week high | $38.4108 |
| 52-week low | $36.5398 |
| Median price | $34.9120 |
| Average price | $34.7985 |
| Largest weekly change | +5.0% (Jan 8, 2025) |
| Weeks tracked | 219 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Atogepant market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QULIPTA 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QULIPTA 10 MG TABLET, manufactured by AbbVie Inc., is $38.3609 per EA (NDC 00074709530), effective Jun 24, 2026.
How has the price of QULIPTA 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for QULIPTA 10 MG TABLET has risen 20.6%. It has been tracked across 219 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for QULIPTA 10 MG TABLET?
Since Apr 20, 2022, the NADAC for QULIPTA 10 MG TABLET has ranged from a low of $31.8211 (Apr 20, 2022) to a high of $38.4108 (Jun 10, 2026), with a median of $34.9120 per EA.
Are there cheaper alternatives to QULIPTA 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QULIPTA 10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures QULIPTA 10 MG TABLET?
QULIPTA 10 MG TABLET (NDC 00074709530) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification